Hamza Suria
Net Worth
Last updated:
What is Hamza Suria net worth?
The estimated net worth of Mr. Hamza Suria is at least $22,275,683 as of 20 Dec 2021. He owns shares worth $1,357,594 as insider, has earned $14,720,359 from insider trading and has received compensation worth at least $6,197,730 in AnaptysBio, Inc..
What is the salary of Hamza Suria?
Mr. Hamza Suria salary is $885,390 per year as Pres, Chief Executive Officer & Director in AnaptysBio, Inc..
How old is Hamza Suria?
Mr. Hamza Suria is 49 years old, born in 1976.
What stocks does Hamza Suria currently own?
As insider, Mr. Hamza Suria owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
AnaptysBio, Inc. (ANAB) | Pres, Chief Executive Officer & Director | 68,600 | $19.79 | $1,357,594 |
What does AnaptysBio, Inc. do?
AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing therapeutic product candidates for inflammation and immuno-oncology indications. Its products include Imsidolimab, an antibody that inhibits the interleukin-36 receptor (IL-36R) for the treatment of various dermatological inflammatory diseases; Rosnilimab, an anti-PD-1 agonist antibody program designed to augment PD-1 signaling through rosnilimab treatment to suppress T-cell driven human inflammatory diseases; and ANB032, an anti-BTLA modulator antibody applicable to human inflammatory diseases associated with lymphoid and myeloid immune cell dysregulation. The company also focuses on developing various antibody programs that are advanced to preclinical and clinical milestones under its collaborations. It has a collaboration and license agreement with GlaxoSmithKline, Inc. and Bristol-Myers Squibb; and license agreements with United Kingdom Research and Innovation, as well as Millipore Corporation. The company was formerly known as Anaptys Biosciences, Inc. and changed its name to AnaptysBio, Inc. in July 2006. AnaptysBio, Inc. was incorporated in 2005 and is based in San Diego, California.
Hamza Suria insider trading
AnaptysBio, Inc.
Mr. Hamza Suria has made 14 insider trades between 2018-2021, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 41,728 units of ANAB stock on 14 Dec 2018. As of 20 Dec 2021 he still owns at least 68,600 units of ANAB stock.
AnaptysBio key executives
AnaptysBio, Inc. executives and other stock owners filed with the SEC:
- Dr. Paul F. Lizzul (50) Chief Medical Officer
- Mr. Dennis M. Mulroy (70) Chief Financial Officer
- Mr. Hamza Suria (49) Pres, Chief Executive Officer & Director